Доступ предоставлен для: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Выходит 6 номеров в год

ISSN Печать: 1045-4403

ISSN Онлайн: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases

Том 10, Выпуск 2, 2000, 20 pages
DOI: 10.1615/CritRevEukarGeneExpr.v10.i2.50
Get accessGet access

Краткое описание

In patients with advanced disease, several cancer types frequently metastasize to the skeleton, where they cause bone destruction. Osteolytic metastases are incurable and cause pain, hypercalcemia, fracture, and nerve compression syndromes. It was proposed over a century ago that certain cancers, such as that of the breast, preferentially metastasize to the favorable microenvironment provided by bone. Bone matrix is a rich store of immobilized growth factors that are released during bone resorption. Histological analysis of osteolytic bone metastases indicates that the bone destruction is mediated by the osteoclast rather than directly by the tumor cells. These observations suggest a vicious cycle driving the formation of osteolytic metastases: tumor cells secrete factors stimulating osteoclasts through adjacent bone marrow stromal cells; osteoclastic resorption in turn releases growth factors from the bone matrix; finally, locally released growth factors activate the tumor cells. This vicious cycle model has now been confirmed at the molecular level. In particular, transforming growth factor β (TGFβ) is abundant in bone matrix and released as a consequence of osteoclastic bone resorption. Bone-derived TGFβ plays an integral role in promoting the development and progression of osteolytic bone metastases by inducing tumor production of parathyroid hormone-related protein (PTHrP), a known stimulator of osteoclastic bone resorption. In breast cancer cells TGFβ appears to stimulate PTHrP secretion by a posttranscriptional mechanism through both Smad and p38 mitogen activated protein (MAP) kinase signaling pathways. Osteolytic metastases can be suppressed in vivo by inhibition of bone resorption, blockade of TGFβ signaling in tumor cells, and by neutralization of PTHrP. Other factors released from bone matrix may also act on tumor cells in bone, which in turn may produce other factors that stimulate bone resorption, following the vicious cycle paradigm established for TGFβ and PTHrP. An understanding at the molecular level of the mechanisms of osteolytic metastasis will result in more effective therapies for this devastating complication of cancer.

ЦИТИРОВАНО В
  1. Gralow Julie, Evolving Role of Bisphosphonates in Women Undergoing Treatment for Localized and Advanced Breast Cancer, Clinical Breast Cancer, 5, 2005. Crossref

  2. Ghobrial Irene M., Myeloma as a model for the process of metastasis: implications for therapy, Blood, 120, 1, 2012. Crossref

  3. Deftos Leonard J, Hypercalcemia in malignant and inflammatory diseases, Endocrinology and Metabolism Clinics of North America, 31, 1, 2002. Crossref

  4. Woodward Julia K. L., Neville-Webbe Helen L., Coleman Robert E., Holen Ingunn, Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro, Anti-Cancer Drugs, 16, 8, 2005. Crossref

  5. Lamoureux François, Trichet Valérie, Chipoy Céline, Blanchard Frédéric, Gouin François, Redini Françoise, Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies, Expert Review of Anticancer Therapy, 7, 2, 2007. Crossref

  6. Endo-Munoz Liliana, Evdokiou Andreas, Saunders Nicholas A., The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1826, 2, 2012. Crossref

  7. Drooger Jan C., van der Padt Annemieke, Sleijfer Stefan, Jager Agnes, Denosumab in breast cancer treatment, European Journal of Pharmacology, 717, 1-3, 2013. Crossref

  8. Gouin François, Ory Benjamin, Rédini François, Heymann Dominique, Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival, International Journal of Cancer, 119, 5, 2006. Crossref

  9. Picarda Gaëlle, Matous Etienne, Amiaud Jérôme, Charrier Céline, Lamoureux François, Heymann Marie-Françoise, Tirode Franck, Pitard Bruno, Trichet Valérie, Heymann Dominique, Redini Françoise, Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL, Journal of Bone Oncology, 2, 3, 2013. Crossref

  10. Domschke Christoph, Ge Yingzi, Bernhardt Isa, Schott Sarah, Keim Sophia, Juenger Simone, Bucur Mariana, Mayer Luisa, Blumenstein Maria, Rom Joachim, Heil Joerg, Sohn Christof, Schneeweiss Andreas, Beckhove Philipp, Schuetz Florian, Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial, Cancer Immunology, Immunotherapy, 62, 6, 2013. Crossref

  11. Ozbas S, Dafydd H, Purushotham A D, Bone marrow micrometastasis in breast cancer, British Journal of Surgery, 90, 3, 2003. Crossref

  12. Georges Steven, Chesneau Julie, Hervouet Soizic, Taurelle Julien, Gouin François, Redini Françoise, Padrines Marc, Heymann Dominique, Fortun Yannick, Verrecchia Franck, A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis, European Journal of Cancer, 49, 9, 2013. Crossref

  13. LeRoy Bruce E., Sellers Rani S., Rosol Thomas J., Canine prostate stimulates osteoblast function using the endothelin receptors, The Prostate, 59, 2, 2004. Crossref

  14. Redini Francoise, Odri Guillaume A, Picarda Gaëlle, Gaspar Nathalie, Heymann Marie-Françoise, Corradini Nadege, Heymann Dominique, Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?, Expert Opinion on Emerging Drugs, 18, 3, 2013. Crossref

  15. Rosol Thomas J., Tannehill-Gregg Sarah H., LeRoy Bruce E., Mandl Stefanie, Contag Christopher H., Animal models of bone metastasis, Cancer, 97, S3, 2003. Crossref

  16. Jilka Robert L., Michael Parfitt A., Stem cells in bone formation growth and remodeling, in Stem Cells: A Cellular Fountain of Youth, 9, 2002. Crossref

  17. Stefanovic Stefan, Schuetz Florian, Sohn Christof, Beckhove Philipp, Domschke Christoph, Adoptive immunotherapy of metastatic breast cancer: present and future, Cancer and Metastasis Reviews, 33, 1, 2014. Crossref

  18. Martin C. K., Dirksen W. P., Carlton M. M., Lanigan L. G., Pillai S. P., Werbeck J. L., Simmons J. K., Hildreth B. E., London C. A., Toribio R. E., Rosol T. J., Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma, Veterinary and Comparative Oncology, 13, 3, 2015. Crossref

  19. Toledo Sílvia Regina Caminada, Oliveira Indhira Dias, Okamoto Oswaldo Keith, Zago Marco Antonio, de Seixas Alves Maria Teresa, Filho Reynaldo Jesus Garcia, Macedo Carla Renata Pacheco Donado, Petrilli Antonio Sergio, Bone deposition, bone resorption, and osteosarcoma, Journal of Orthopaedic Research, 28, 9, 2010. Crossref

  20. Dougall William C., Chaisson Michelle, The RANK/RANKL/OPG triad in cancer-induced bone diseases, Cancer and Metastasis Reviews, 25, 4, 2007. Crossref

  21. Corradini Nadège, Redini Françoise, New therapeutic targets in Ewing sarcoma: from pre-clinical proof-of-concept to clinical trials, in Bone Cancer, 2015. Crossref

  22. Thomas Christian, Lamoureux Francois, Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view, in Bone Cancer, 2015. Crossref

  23. Bonucci Ermanno, Physiopathology of cancer metastases in bone and of the changes they induce in bone remodeling, Rendiconti Lincei, 13, 3, 2002. Crossref

  24. Liapis Vasilios, Labrinidis Agatha, Zinonos Irene, Hay Shelley, Ponomarev Vladimir, Panagopoulos Vasilios, DeNichilo Mark, Ingman Wendy, Atkins Gerald J., Findlay David M., Zannettino Andrew C.W., Evdokiou Andreas, Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma, Cancer Letters, 357, 1, 2015. Crossref

  25. Roccaro Aldo M., Sacco Antonio, Purschke Werner G., Moschetta Michele, Buchner Klaus, Maasch Christian, Zboralski Dirk, Zöllner Stefan, Vonhoff Stefan, Mishima Yuji, Maiso Patricia, Reagan Michaela R., Lonardi Silvia, Ungari Marco, Facchetti Fabio, Eulberg Dirk, Kruschinski Anna, Vater Axel, Rossi Giuseppe, Klussmann Sven, Ghobrial Irene M., SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy, Cell Reports, 9, 1, 2014. Crossref

  26. Reddi A Hari, Roodman David, Freeman Colette, Mohla Suresh, Mechanisms of Tumor Metastasis to the Bone: Challenges and Opportunities, Journal of Bone and Mineral Research, 18, 2, 2003. Crossref

  27. Labrinidis Agatha, Hay Shelley, Liapis Vasilios, Findlay David M., Evdokiou Andreas, Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model, International Journal of Cancer, 2010. Crossref

  28. Goldstein Robert H, Weinberg Robert A, Rosenblatt Michael, Of mice and (wo)men: Mouse models of breast cancer metastasis to bone, Journal of Bone and Mineral Research, 25, 3, 2010. Crossref

  29. Goltzman David, Osteolysis and cancer, Journal of Clinical Investigation, 107, 10, 2001. Crossref

  30. YIN Juan Juan, POLLOCK Claire B, KELLY Kathleen, Mechanisms of cancer metastasis to the bone, Cell Research, 15, 1, 2005. Crossref

  31. Holzer G., Bisphosphonate bei malignen Knochentumoren, Der Orthopäde, 38, 4, 2009. Crossref

  32. Saltel Frédéric, Chabadel Anne, Zhao Yingshe, Lafage-Proust Marie-Hélène, Clézardin Philippe, Jurdic Pierre, Bonnelye Edith, Transmigration: A New Property of Mature Multinucleated Osteoclasts, Journal of Bone and Mineral Research, 21, 12, 2006. Crossref

  33. Sato Shinya, Futakuchi Mitsuru, Ogawa Kumiko, Asamoto Makoto, Nakao Kimihisa, Asai Kiyofumi, Shirai Tomoyuki, Transforming growth factor β derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment, Cancer Science, 99, 2, 2008. Crossref

  34. Pinheiro J J V, Freitas V M, Moretti A I S, Jorge A G, Jaeger R G, Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity, Histopathology, 45, 1, 2004. Crossref

  35. Sung Shian-Ying, Chung Leland W.K., Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting, Differentiation, 70, 9-10, 2002. Crossref

  36. Dorai Thambi, Dutcher Janice P., Dempster David W., Wiernik Peter H., Therapeutic potential of curcumin in prostate cancer?IV: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells, The Prostate, 60, 1, 2004. Crossref

  37. Roodman G. David, Genes associate with abnormal bone cell activity in bone metastasis, Cancer and Metastasis Reviews, 31, 3-4, 2012. Crossref

  38. Hans Guy, Deseure Kristof, Robert Dominique, De Hert Stefan, Neurosensory changes in a human model of endothelin-1 induced pain: A behavioral study, Neuroscience Letters, 418, 2, 2007. Crossref

  39. Hussein Osama, Komarova Svetlana V., Breast cancer at bone metastatic sites: recent discoveries and treatment targets, Journal of Cell Communication and Signaling, 5, 2, 2011. Crossref

  40. Mori K., Le Goff B., Charrier C., Battaglia S., Heymann D., Rédini F., DU145 human prostate cancer cells express functional receptor activator of NFκB: New insights in the prostate cancer bone metastasis process, Bone, 40, 4, 2007. Crossref

  41. Ray David W., Ectopic Hormone Syndromes, in Endocrinology: Adult and Pediatric, 2016. Crossref

  42. Hussein Osama, Tiedemann Kerstin, Murshed Monzur, Komarova Svetlana V., Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases, Cancer Letters, 314, 2, 2012. Crossref

  43. Ramnaraine Margaret, Pan Weihong, Clohisy Denis R., Osteoclasts direct bystander killing of cancer cells in vitro, Bone, 38, 1, 2006. Crossref

  44. Henriques Águida Cristina Gomes, Vasconcelos Marcelo Gadelha, Galvão Hébel Cavalcanti, de Souza Lélia Batista, de Almeida Freitas Roseana, Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112, 4, 2011. Crossref

  45. Wittrant Y., Théoleyre S., Chipoy C., Padrines M., Blanchard F., Heymann D., Rédini F., RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1704, 2, 2004. Crossref

  46. Heymann D., Ory B., Blanchard F., Heymann M-F., Coipeau P., Charrier C., Couillaud S., Thiery J.P., Gouin F., Redini F., Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma, Bone, 37, 1, 2005. Crossref

  47. Singh Balraj, Lucci Anthony, Role of Cyclooxygenase-2 in Breast Cancer, Journal of Surgical Research, 108, 1, 2002. Crossref

  48. Susa Takao, Ikaga Reina, Kajitani Takashi, Iizuka Masayoshi, Okinaga Hiroko, Tamamori‐Adachi Mimi, Okazaki Tomoki, Wild‐type and specific mutant androgen receptor mediates transcription via 17β‐estradiol in sex hormone‐sensitive cancer cells, Journal of Cellular Physiology, 230, 7, 2015. Crossref

  49. Sung Shian-Ying, Hsieh Chia-Ling, Wu Daqing, Chung Leland W.K., Johnstone Peter A.S., Tumor Microenvironment Promotes Cancer Progression, Metastasis, and Therapeutic Resistance, Current Problems in Cancer, 31, 2, 2007. Crossref

  50. Kehl Lois J, Hamamoto Darryl T, Wacnik Paul W, Croft Devin L, Norsted Blake D, Wilcox George L, Simone Donald A, A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain, Pain, 103, 1, 2003. Crossref

  51. Rousseau Julie, Escriou Virginie, Lamoureux François, Brion Régis, Chesneau Julie, Battaglia Séverine, Amiaud Jérome, Scherman Daniel, Heymann Dominique, Rédini Françoise, Trichet Valérie, Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models, Journal of Bone and Mineral Research, 26, 10, 2011. Crossref

  52. Molinuevo M. Silvina, Bruzzone Liliana, Cortizo Ana M., Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells, European Journal of Pharmacology, 562, 1-2, 2007. Crossref

  53. Muraro M., Mereuta O.M., Carraro F., Madon E., Fagioli F., Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells, Cellular Immunology, 249, 2, 2007. Crossref

  54. Yagiz Kader, Rittling Susan R, Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation, Experimental Cell Research, 315, 14, 2009. Crossref

  55. Heymann Dominique, Ory Benjamin, Gouin François, Green Jonathan R, Rédini Françoise, Bisphosphonates: new therapeutic agents for the treatment of bone tumors, Trends in Molecular Medicine, 10, 7, 2004. Crossref

  56. Selvaggi Giovanni, Scagliotti Giorgio V., Management of bone metastases in cancer: A review, Critical Reviews in Oncology/Hematology, 56, 3, 2005. Crossref

  57. Guise Theresa A., Kozlow Wende M., Heras-Herzig Ailleen, Padalecki Susan S., Yin Juan Juan, Chirgwin John M., Molecular Mechanisms of Breast Cancer Metastases to Bone, Clinical Breast Cancer, 5, 2005. Crossref

  58. Marley Kevin, Bracha Shay, Seguin Bernard, Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL, Experimental Cell Research, 338, 1, 2015. Crossref

  59. Schramek Daniel, Penninger Josef M, The many roles of RANKL-RANK signaling in bone, breast and cancer, IBMS BoneKEy, 8, 5, 2011. Crossref

  60. Mandal Chandi C., High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms, Frontiers in Endocrinology, 6, 2015. Crossref

  61. Roodman G. David, Mechanisms of Bone Metastasis, New England Journal of Medicine, 350, 16, 2004. Crossref

  62. Chirgwin John M., Guise Theresa A., Molecular mechanisms of cancer metastases to bone, Current Opinion in Orthopaedics, 14, 5, 2003. Crossref

  63. Schmit J.M., Pondenis H.C., Barger A.M., Borst L.B., Garrett L.D., Wypij J.M., Neumann Z.L., Fan T.M., Cathepsin K Expression and Activity in Canine Osteosarcoma, Journal of Veterinary Internal Medicine, 26, 1, 2012. Crossref

  64. Morales Monica, Planet Evarist, Arnal-Estape Anna, Pavlovic Milica, Tarragona Maria, Gomis Roger R., Tumor-stroma interactions a trademark for metastasis, The Breast, 20, 2011. Crossref

  65. Kajitani Takashi, Tamamori-Adachi Mimi, Okinaga Hiroko, Chikamori Minoru, Iizuka Masayoshi, Okazaki Tomoki, Negative regulation of parathyroid hormone-related protein expression by steroid hormones, Biochemical and Biophysical Research Communications, 407, 3, 2011. Crossref

  66. Wang Ruoxiang, Xu Jianchun, Juliette Lisa, Castilleja Agapito, Love John, Sung Shian-Ying, Zhau Haiyen E., Goodwin Thomas J., Chung Leland W.K., Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone, Seminars in Cancer Biology, 15, 5, 2005. Crossref

  67. Ruhin B., Descroix V., Picard A., Berdal A., Tumorogenèse des maxillaires. Recherche et perspective, Revue de Stomatologie et de Chirurgie Maxillo-faciale, 110, 4, 2009. Crossref

  68. Yuan Jun, Ossendorf Christian, Szatkowski Jan P., Bronk James T., Maran Avudaiappan, Yaszemski Michael, Bolander Mark E., Sarkar Gobinda, Fuchs Bruno, Osteoblastic and Osteolytic Human Osteosarcomas can be Studied With a New Xenograft Mouse Model Producing Spontaneous Metastases, Cancer Investigation, 27, 4, 2009. Crossref

  69. Lynch Conor C., Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis, Bone, 48, 1, 2011. Crossref

  70. Martin Chelsea K., Dirksen Wessel P., Shu Sherry T., Werbeck Jillian L., Thudi Nanda K., Yamaguchi Mamoru, Wolfe Tobie D., Heller Kristin N., Rosol Thomas J., Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma, Oral Oncology, 48, 6, 2012. Crossref

  71. Redini Françoise, Heymann Dominique, Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma, Frontiers in Oncology, 5, 2015. Crossref

  72. Li Qingsong, Zhang Xi, Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model, International Immunopharmacology, 29, 2, 2015. Crossref

  73. Zhang Zhongzu, Li Yunyun, Huang Lu, Xiao Qianren, Chen Xiang, Zhong Junlong, Chen Yiwei, Yang Dong, Han Zhimin, Shu Yong, Dai Min, Cao Kai, Let-7a suppresses macrophage infiltrations and malignant phenotype of Ewing sarcoma via STAT3/NF-κB positive regulatory circuit, Cancer Letters, 374, 2, 2016. Crossref

  74. Kim Wonnam, Wysolmerski John J., Calcium-Sensing Receptor in Breast Physiology and Cancer, Frontiers in Physiology, 7, 2016. Crossref

  75. Lau Wen Min, Doucet Michele, Stadel Ryan, Huang David, Weber Kristy L., Kominsky Scott L., Oshima Robert, Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis, PLoS ONE, 8, 7, 2013. Crossref

  76. Baier Scott R., Wan Yihong, MicroRNA Exert Macro Effects on Cancer Bone Metastasis, Current Osteoporosis Reports, 14, 5, 2016. Crossref

  77. Breuksch Ines, Weinert Maria, Brenner Walburgis, The role of extracellular calcium in bone metastasis, Journal of Bone Oncology, 5, 3, 2016. Crossref

  78. Jiang Zongming, Wu Shaoyong, Wu Xiujuan, Zhong Junfeng, Lv Anqing, Jiao Jing, Chen Zhonghua, Blocking mammalian target of rapamycin alleviates bone cancer pain and morphine toleranceviaµ-opioid receptor, International Journal of Cancer, 138, 8, 2016. Crossref

  79. Farina Anne K., Bong Yong-Sik, Feltes Carolyn M., Byers Stephen W., Klefstrom Juha, Post-Transcriptional Regulation of Cadherin-11 Expression by GSK-3 and β-Catenin in Prostate and Breast Cancer Cells, PLoS ONE, 4, 3, 2009. Crossref

  80. Ono Mitsuaki, Inkson Colette A., Sonn Robert, Kilts Tina M., de Castro Luis F., Maeda Azusa, Fisher Larry W., Robey Pamela G., Berendsen Agnes D., Li Li, McCartney-Francis Nancy, Brown Aaron C., Crawford Nigel P. S., Molinolo Alfredo, Jain Alka, Fedarko Neal S., Young Marian F., Batra Surinder K., WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone, PLoS ONE, 8, 8, 2013. Crossref

  81. Liapis Vasilios, Zysk Aneta, DeNichilo Mark, Zinonos Irene, Hay Shelley, Panagopoulos Vasilios, Shoubridge Alexandra, Difelice Christopher, Ponomarev Vladimir, Ingman Wendy, Atkins Gerald J., Findlay David M., Zannettino Andrew C. W., Evdokiou Andreas, Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma, Cancer Medicine, 6, 9, 2017. Crossref

  82. Liu Jin, Li Defang, Dang Lei, Liang Chao, Guo Baosheng, Lu Cheng, He Xiaojuan, Cheung Hilda Y. S., He Bing, Liu Biao, Li Fangfei, Lu Jun, Wang Luyao, Shaikh Atik Badshah, Jiang Feng, Lu Changwei, Peng Songlin, Zhang Zongkang, Zhang Bao-Ting, Pan Xiaohua, Xiao Lianbo, Lu Aiping, Zhang Ge, Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer, Scientific Reports, 7, 1, 2017. Crossref

  83. Body Jean-Jacques, Niepel Daniela, Tonini Giuseppe, Hypercalcaemia and hypocalcaemia: finding the balance, Supportive Care in Cancer, 25, 5, 2017. Crossref

  84. Wang Li, Widatalla Sarrah E., Whalen Diva S., Ochieng Josiah, Sakwe Amos M., Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients, BMC Cancer, 17, 1, 2017. Crossref

  85. Secondini Chiara, Wetterwald Antoinette, Schwaninger Ruth, Thalmann George N., Cecchini Marco G., Creighton Chad, The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis, PLoS ONE, 6, 1, 2011. Crossref

  86. Guise Theresa A., Chirgwin John M., Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone Metastases, Clinical Orthopaedics and Related Research, 415, 2003. Crossref

  87. Serganova Inna, Moroz Ekaterina, Vider Jelena, Gogiberidze George, Moroz Maxim, Pillarsetty Nagavarakishore, Doubrovin Michael, Minn Andy, Thaler Howard T., Massague Joan, Gelovani Juri, Blasberg Ronald, Multimodality imaging of TGFβ signaling in breast cancer metastases, The FASEB Journal, 23, 8, 2009. Crossref

  88. Demers Laurence M., Costa Luis, Lipton Allan, Biochemical Markers and Skeletal Metastases, Clinical Orthopaedics and Related Research, 415, 2003. Crossref

  89. David Roodman G., Role of stromal-derived cytokines and growth factors in bone metastasis, Cancer, 97, S3, 2003. Crossref

  90. Chung Leland W. K., Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications, Cancer, 97, S3, 2003. Crossref

  91. Park Sun, Eber Matthew, Widner D., Shiozawa Yusuke, Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases, Cancers, 10, 5, 2018. Crossref

  92. Reddy Sakamuri V., Roodman G. David, Osteoclast Differentiation, in The Skeleton, 2004. Crossref

  93. Athanasou Nicholas A., The Role of Tumor-Associated Macrophages in Metastasis-Associated Osteolysis, in Bone Metastasis and Molecular Mechanisms, 6, 2004. Crossref

  94. Parker Belinda S., Eckhardt Bedrich L., Anderson Robin L., Models of Breast Cancer Metastasis to Bone: Characterization of a Clinically Relevant Model, in Bone Metastasis and Molecular Mechanisms, 6, 2004. Crossref

  95. Brewer Takae M., Theriault Richard L., Ueno Naoto T., Bone Metastasis of Breast Cancer, in Breast Cancer Metastasis and Drug Resistance, 2013. Crossref

  96. Lamoureux Francois, Zoubeidi Amina, Gleave Martin E., Molecular Mechanisms of Castrate Resistant Prostate Cancer, in Prostate Cancer: A Comprehensive Perspective, 2013. Crossref

  97. Clines Gregory A., Chirgwin John M., Guise Theresa A., Skeletal Complications of Malignancy: Central Role for the Osteoclast, in Bone Resorption, 2, 2005. Crossref

  98. Kremer Richard, Li Jiarong, Camirand Anne, Karaplis Andrew C., Parathyroid Hormone Related Protein (PTHrP) in Tumor Progression, in Human Cell Transformation, 720, 2011. Crossref

  99. Terpos Evangelos, Syrigos Konstantinos N., Pathophysiology and Management of Bone Metastases in Lung Cancer, in Tumors of the Chest, 2006. Crossref

  100. Tahara Rie K., Brewer Takae M., Theriault Richard L., Ueno Naoto T., Bone Metastasis of Breast Cancer, in Breast Cancer Metastasis and Drug Resistance, 1152, 2019. Crossref

  101. Krzeszinski Jing Y., Schwaid Adam G., Cheng Wing Yin, Jin Zixue, Gallegos Zachary R., Saghatelian Alan, Wan Yihong, Lipid Osteoclastokines Regulate Breast Cancer Bone Metastasis, Endocrinology, 158, 3, 2017. Crossref

  102. Tu Chia-Ling, Chang Wenhan, Shoback Dolores M., Biology of the extracellular calcium-sensing receptor, in Principles of Bone Biology, 2020. Crossref

  103. Reiss Michael, Targeting Transforming Growth Factor-β in Metastasis: In Vitro and In Vivo Mechanisms, in Transforming Growth Factor-β in Cancer Therapy, Volume II, 2008. Crossref

  104. Bartholin Laurent, Guise Theresa, Role of TGF-β in Osteolytic Bone Metastases, in Transforming Growth Factor-β in Cancer Therapy, Volume II, 2008. Crossref

  105. Vassiliou Vassilios, Kardamakis Dimitrios, Combined Radiotherapy and Bisphosphonates: State of Art, in Bone Metastases, 12, 2009. Crossref

  106. Roodman G. David., Pathophysiology of Bone Metastases, in Bone Metastases, 12, 2009. Crossref

  107. Chiechi Antonella, Guise Theresa A., Pathobiology of Osteolytic and Osteoblastic Bone Metastases, in Metastatic Bone Disease, 2016. Crossref

  108. Altavilla Giuseppe, Marabello Grazia, Tomasello Chiara, Pitini Vincenzo, Use of Bisphosphonates in Oncology, in Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach, 2012. Crossref

  109. Surowiak Paweł, Dzięgiel Piotr, Matkowski Rafał, Sopel Mirosław, Wojnar Andrzej, Kornafel Jan, Zabel Maciej, Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course, Virchows Archiv, 442, 3, 2003. Crossref

  110. Hsu Yu-Hsiang, Hsing Chung-Hsi, Li Chien-Feng, Chan Chien-Hui, Chang Ming-Chung, Yan Jing-Jou, Chang Ming-Shi, Anti–IL-20 Monoclonal Antibody Suppresses Breast Cancer Progression and Bone Osteolysis in Murine Models, The Journal of Immunology, 188, 4, 2012. Crossref

  111. Ray David W., Ectopic Hormone Syndromes, in Endocrinology, 2010. Crossref

  112. Zuo Hao, Yang Dengbao, Yang Qiwen, Tang Haidong, Fu Yang-Xin, Wan Yihong, Differential regulation of breast cancer bone metastasis by PARP1 and PARP2, Nature Communications, 11, 1, 2020. Crossref

  113. Lu Ko-Hsiu, Lu Eric Wun-Hao, Lin Chiao-Wen, Yang Jia-Sin, Yang Shun-Fa, New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma, Pharmacology & Therapeutics, 214, 2020. Crossref

  114. Wu Xiaoqiu, Li Fangfei, Dang Lei, Liang Chao, Lu Aiping, Zhang Ge, RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies, Frontiers in Cell and Developmental Biology, 8, 2020. Crossref

  115. Patel Anery, Graeff-Armas Laura, Ross Meredith, Goldner Whitney, Hypercalcemia, in Abeloff's Clinical Oncology, 2020. Crossref

  116. Dvorak Melita M., Chen Tsui-Hua, Orwoll Benjamin, Garvey Caitlin, Chang Wenhan, Bikle Daniel D., Shoback Dolores M., Constitutive Activity of the Osteoblast Ca2+-Sensing Receptor Promotes Loss of Cancellous Bone, Endocrinology, 148, 7, 2007. Crossref

  117. Rabbani S. A., Khalili P., Arakelian A., Pizzi H., Chen G., Goltzman D., Regulation of Parathyroid Hormone-Related Peptide by Estradiol: Effect on Tumor Growth and Metastasis in Vitro and in Vivo, Endocrinology, 146, 7, 2005. Crossref

  118. Ban Jozef, Fock Valerie, Aryee Dave N. T., Kovar Heinrich, Mechanisms, Diagnosis and Treatment of Bone Metastases, Cells, 10, 11, 2021. Crossref

  119. Leakey Julian E.A., Ali A. Afshan, Babb Amy R., Badgley Heidi L., Davis Kelly J., Juliar Beth E., Leakey Tatiana I., Lewis Sherry M., Patton Ralph E., Seng John E., Subchronic toxicity evaluation of glucosamine and glucosamine in combination with chondroitin sulfate in obese Zucker rats, Toxicology and Applied Pharmacology, 412, 2021. Crossref

  120. Fan Ying, Dong Yue, Yang Huazhe, Chen Huanhuan, Yu Yalian, Wang Xiaoyu, Wang Xinling, Yu Tao, Luo Yahong, Jiang Xiran, Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer, Physics in Medicine & Biology, 66, 21, 2021. Crossref

  121. Chhichholiya Yogita, Suman Prabhat, Singh Sandeep, Munshi Anjana, The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies, Medical Oncology, 38, 8, 2021. Crossref

  122. Lamoureux Francois, Therapies of bone metastases in castration-resistant prostate cancer, in Bone Cancer, 2022. Crossref

  123. Li Ke-Xin, Sun Xun, Li Bai-Yan, Yokota Hiroki, Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells, Cancers, 13, 22, 2021. Crossref

  124. Dieterly Alexandra M., Uzunalli Gozde, Kemet Chinyere M., Soepriatna Arvin H., Goergen Craig J., Lyle L. Tiffany, Epithelial–mesenchymal Transition Phenotypes in Vertebral Metastases of Lung Cancer, Toxicologic Pathology, 47, 4, 2019. Crossref

  125. Santoni Matteo, Conti Alessandro, Procopio Giuseppe, Porta Camillo, Ibrahim Toni, Barni Sandro, Guida Francesco Maria, Fontana Andrea, Berruti Alfredo, Berardi Rossana, Massari Francesco, Vincenzi Bruno, Ortega Cinzia, Ottaviani Davide, Carteni Giacomo, Lanzetta Gaetano, De Lisi Delia, Silvestris Nicola, Satolli Maria Antonietta, Collovà Elena, Russo Antonio, Badalamenti Giuseppe, Luzi Fedeli Stefano, Tanca Francesca Maria, Adamo Vincenzo, Maiello Evaristo, Sabbatini Roberto, Felici Alessandra, Cinieri Saverio, Montironi Rodolfo, Bracarda Sergio, Tonini Giuseppe, Cascinu Stefano, Santini Daniele, Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?, Journal of Experimental & Clinical Cancer Research, 34, 1, 2015. Crossref

  126. Picarda Gaëlle, Lamoureux François, Geffroy Loïc, Delepine Pascal, Montier Tristan, Laud Karine, Tirode Franck, Delattre Olivier, Heymann Dominique, Rédini Françoise, Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival, Clinical Cancer Research, 16, 8, 2010. Crossref

  127. Hsu Y-L, Hou M-F, Kuo P-L, Huang Y-F, Tsai E-M, Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway, Oncogene, 32, 37, 2013. Crossref

  128. Labrinidis Agatha, Hay Shelley, Liapis Vasilios, Ponomarev Vladimir, Findlay David M., Evdokiou Andreas, Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model, Clinical Cancer Research, 15, 10, 2009. Crossref

  129. Phadke Pushkar A., Mercer Robyn R., Harms John F., Jia Yujiang, Frost Andra R., Jewell Jennifer L., Bussard Karen M., Nelson Shakira, Moore Cynthia, Kappes John C., Gay Carol V., Mastro Andrea M., Welch Danny R., Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone, Clinical Cancer Research, 12, 5, 2006. Crossref

  130. Begum Salma, Emani Nashmil, Cheung Albert, Wilkins Olivia, Der Sandy, Hamel Paul A, Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR, Oncogene, 24, 11, 2005. Crossref

  131. Fong Jenna E., Le Nihouannen Damien, Komarova Svetlana V., Tumor-supportive and Osteoclastogenic Changes Induced by Breast Cancer-derived Factors Are Reversed by Inhibition of γ-Secretase, Journal of Biological Chemistry, 285, 41, 2010. Crossref

  132. Beasley Heather K., Widatalla Sarrah E., Whalen Diva S., Williams Stephen D., Korolkova Olga Y., Namba Clementine, Pratap Siddharth, Ochieng Josiah, Sakwe Amos M., Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer, Frontiers in Endocrinology, 13, 2022. Crossref

  133. Lev Dina Chelouche, Kim Sun Jin, Onn Amir, Stone Valerie, Nam Do-Hyun, Yazici Sertac, Fidler Isaiah J., Price Janet E., Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice, Clinical Cancer Research, 11, 1, 2005. Crossref

  134. Martin Chelsea K., Werbeck Jillian L., Thudi Nanda K., Lanigan Lisa G., Wolfe Tobie D., Toribio Ramiro E., Rosol Thomas J., Zoledronic Acid Reduces Bone Loss and Tumor Growth in an Orthotopic Xenograft Model of Osteolytic Oral Squamous Cell Carcinoma, Cancer Research, 70, 21, 2010. Crossref

  135. Miller Robert E., Roudier Martine, Jones Jon, Armstrong Allison, Canon Jude, Dougall William C., RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis, Molecular Cancer Therapeutics, 7, 7, 2008. Crossref

  136. Karsdal Morten A., Hjorth Pernille, Henriksen Kim, Kirkegaard Tove, Nielsen Karina L., Lou Henriette, Delaissé Jean-Marie, Foged Niels T., Transforming Growth Factor-β Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression, Journal of Biological Chemistry, 278, 45, 2003. Crossref

  137. Thiolloy Sophie, Halpern Jennifer, Holt Ginger E., Schwartz Herbert S., Mundy Gregory R., Matrisian Lynn M., Lynch Conor C., Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis, Cancer Research, 69, 16, 2009. Crossref

  138. Lamoureux François, Richard Peggy, Wittrant Yohann, Battaglia Séverine, Pilet Paul, Trichet Valérie, Blanchard Frédéric, Gouin François, Pitard Bruno, Heymann Dominique, Redini Françoise, Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption, Cancer Research, 67, 15, 2007. Crossref

  139. Mintz Michelle B., Sowers Rebecca, Brown Kevin M., Hilmer Sara C., Mazza BethAnne, Huvos Andrew G., Meyers Paul A., LaFleur Bonnie, McDonough Wendy S., Henry Michael M., Ramsey Keri E., Antonescu Cristina R., Chen Wen, Healey John H., Daluski Aaron, Berens Michael E., MacDonald Tobey J., Gorlick Richard, Stephan Dietrich A., An Expression Signature Classifies Chemotherapy-Resistant Pediatric Osteosarcoma, Cancer Research, 65, 5, 2005. Crossref

  140. Coulson-Thomas Vivien J., Gesteira Tarsis F., Coulson-Thomas Yvette M., Vicente Carolina M., Tersariol Ivarne L.S., Nader Helena B., Toma Leny, Fibroblast and prostate tumor cell cross-talk: Fibroblast differentiation, TGF-β, and extracellular matrix down-regulation, Experimental Cell Research, 316, 19, 2010. Crossref

  141. Domschke Christoph, Schneeweiss Andreas, Stefanovic Stefan, Wallwiener Markus, Heil Joerg, Rom Joachim, Sohn Christof, Beckhove Philipp, Schuetz Florian, Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy, Breast Care, 11, 2, 2016. Crossref

  142. Zuo Hao, Yang Dengbao, Wan Yihong, Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4, Cancer Research, 81, 20, 2021. Crossref

  143. Titus Brian, Frierson Henry F., Conaway Mark, Ching Keith, Guise Theresa, Chirgwin John, Hampton Garret, Theodorescu Dan, Endothelin Axis Is a Target of the Lung Metastasis Suppressor Gene RhoGDI2 , Cancer Research, 65, 16, 2005. Crossref

Статьи, принятые к публикации

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain